P

Inventor

TINTI MARIA ORNELLA

IT40 patents
⚠️ This page may combine multiple inventors who share the name “TINTI MARIA ORNELLA”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

SIGMA TAU IND FARMACEUTI

33 patents
US6369073B1Apr 9, 2002

Compounds having reversible inhibiting activity of carnitine palmitoyl-transferase

SIGMA TAU IND FARMACEUTI95 citations96
US6337349B2Jan 8, 2002

Solid compositions suitable for oral administration comprising an alkanoyl-l-carnitine magnesium citrate

SIGMA TAU IND FARMACEUTI28 citations92
US6444701B1Sep 3, 2002

Compounds having reversible inhibiting activity of carnitine palmitoyl-transferase

SIGMA TAU IND FARMACEUTI19 citations91
US6420599B2Jul 16, 2002

Chemical process for the stereoselective synthesis of R-(-)-carnitine

SIGMA TAU IND FARMACEUTI7 citations73
US6051608AApr 18, 2000

Solid compositions suitable for oral administration comprising L-carnitine or alkanoyl-L-carnitine magnesium fumarate

SIGMA TAU IND FARMACEUTI14 citations73
US6180667B1Jan 30, 2001

Esters of acyl L-carnitines and pharmaceutical compositions containing same for treating endotoxic shock

SIGMA TAU IND FARMACEUTI5 citations72
US6822115B2Nov 23, 2004

Synthesis of (R) and (S)-aminocarnitine, (R) and (S)-4-phosphonium-3-amino-butanoate, (R) and (S) 3,4-diaminobutanoic acid, and their derivatives starting from D- and L-aspartic acid

SIGMA TAU IND FARMACEUTI8 citations71
US6797281B1Sep 28, 2004

Esters of I-carnitine or alkanoyl I-carnitines

SIGMA TAU IND FARMACEUTI9 citations71
US6566552B2May 20, 2003

Industrial process for the production of L-carnitine

SIGMA TAU IND FARMACEUTI7 citations71
US6528684B1Mar 4, 2003

Synthesis of (R) and (S) -aminocarnitine and their derivatives starting from D- and L-aspartic acid

SIGMA TAU IND FARMACEUTI10 citations71
US6130249AOct 10, 2000

Solid compositions suitable for oral administration comprising L-carnitine and alkanoyl-L-carnitine magnesium tartrate

SIGMA TAU IND FARMACEUTI3 citations62
US6127552AOct 3, 2000

Process for producing (R)-3-hydroxy-4-butyrolactone useful for preparing (R)-carnitine

SIGMA TAU IND FARMACEUTI2 citations62
US6124360ASep 26, 2000

Solid compositions suitable for oral administration comprising non hygroscopic salts of L-carnitine and alkanoyl-L-carnitine with 2-aminoethanesulfonic acid

SIGMA TAU IND FARMACEUTI3 citations62
US6080786AJun 27, 2000

Solid compositions suitable for oral administration comprising L-carnitine or alkanoyl-L-carnitine choline tartrate

SIGMA TAU IND FARMACEUTI2 citations62
US5962525AOct 5, 1999

6,7-disubstituted-2-aminotetralines active as immunomodulators and pharmaceutical compositions containing same

SIGMA TAU IND FARMACEUTI4 citations62
USRE41226EApr 13, 2010

Compounds having reversible inhibiting activity of carnitine palmitoyl-transferase

SIGMA TAU IND FARMACEUTI1 citations61
US7498340B2Mar 3, 2009

Esters in position 20 of camptothecins

SIGMA TAU IND FARMACEUTI4 citations61
US7629003B2Dec 8, 2009

Esters of L-carnitine of alkanoyl L-carnitines useful as cationic lipids for the intracellular delivery of pharmacologically active compounds

SIGMA TAU IND FARMACEUTI2 citations60
US7705012B2Apr 27, 2010

Camptothecins conjugated in position 7 to cyclic peptides as cytostatic agents

SIGMA TAU IND FARMACEUTI4 citations59
US7452900B2Nov 18, 2008

Esters in position 20 of camptothecins

SIGMA TAU IND FARMACEUTI5 citations55
US7858820B2Dec 28, 2010

Solid compositions suitable for oral administration containing non-hygroscopic salts of L-carnitine and the alkanoyl L-carnitines with taurine chloride and glycine chloride

SIGMA TAU IND FARMACEUTI0 citations52
US6887892B2May 3, 2005

Tricyclic derivatives of indole with antiangiogenic activity

SIGMA TAU IND FARMACEUTI1 citations52
US6316667B2Nov 13, 2001

Process for the preparation of R-(-)-carnitine

SIGMA TAU IND FARMACEUTI0 citations52
US6465515B2Oct 15, 2002

Solid compositions suitable for oral administration containing non-hydroscopic salts of L-carnitine and alkanoyl L-carnitines

SIGMA TAU IND FARMACEUTI0 citations51
US7799921B2Sep 21, 2010

Stereoselective process and crystalline forms of a camptothecin

SIGMA TAU IND FARMACEUTI0 citations50
US7713956B2May 11, 2010

Dealkylated derivatives of pyrrolo[2,1-b]benzothiazepines with atypical antipsychotic activity

SIGMA TAU IND FARMACEUTI0 citations50
US7589099B2Sep 15, 2009

7-t-butoxyiminomethylcamptothecin conjugated in position 20 with integrin antagonists

SIGMA TAU IND FARMACEUTI1 citations49
US7585519B2Sep 8, 2009

Esters of L-carnitine or alkanoyl L-carnitines useful as cationic lipids for the intracellular delivery of pharmacologically active compounds

SIGMA TAU IND FARMACEUTI0 citations49
US7572778B2Aug 11, 2009

Fluorocombretastatin and derivatives thereof

SIGMA TAU IND FARMACEUTI0 citations46
US6476243B1Nov 5, 2002

Perfluorinated esters of alkanoyl L-carnitine for the preparation of cationic lipids for the intracellular delivery of pharmacologically active compounds

SIGMA TAU IND FARMACEUTI0 citations42
US7375124B2May 20, 2008

Use of α-phenylthiocarboxylic and α-phenyloxycarboxylic acids with serum-glucose-lowering and serum-lipid-lowering activity

SIGMA TAU IND FARMACEUTI0 citations40
US7169808B2Jan 30, 2007

Compounds useful for the preparation of medicaments with phosphodiesterase IV inhibitory activity

SIGMA TAU IND FARMACEUTI0 citations39
US7368605B2May 6, 2008

Variously substituted derivatives of guanidine, and their use as medicines with anti-diabetes and/or anti-obesity activity

SIGMA TAU IND FARMACEUTI0 citations33

CARMINATI PAOLO

2 patents

(unassigned)

1 patent

SIGMA TAU HEALTHSCIENCE SPA

1 patent

SIGMA TAU IND FARMACEUTICHEE R

1 patent

IST NAZ STUD CURA DEI TUMORI

1 patent

INST NAZ PER LO STUDIO E LA CU

1 patent